Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Glucagon-like peptide-1: a potent regulator of food intake in humans
1999
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Increase in clinically recorded type 2 diabetes after colectomy
2018
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
1997
6-18F-Fluoro-l -Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: Correlation with Vesicular Monoamine Transporter Expression
2010
Bioactive peptides, networks and systems biology
2009
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum
2003
Pathophysiology of Progressive Nephropathies
1998 Standout
Distal Small Bowel Hormones (Correlation with Fasting Antroduodenal Motility and Gastric Emptying)
1998
The neurotransmitters glycine and GABA stimulate glucagon‐like peptide‐1 release from the GLUTag cell line
2005
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Anatomy and regulation of the central melanocortin system
2005 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Unraveling the Science of Incretin Biology
2009
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
1993
What do we know about the secretion and degradation of incretin hormones?
2005
The Physiology of Gastric Acid Secretion
1988
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth
2015
The biology of incretin hormones
2006 Standout
Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
2013
Role of prohormone convertases in the tissue-specific processing of proglucagon.
1996
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis
1991
The Glucagon‐Like Peptides
2006
Electrical activity‐triggered glucagon‐like peptide‐1 secretion from primary murine L‐cells
2011
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth
2001
Control of Gastric Acid Secretion in Health and Disease
2008
Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36
1994
Biology of Incretins: GLP-1 and GIP
2007 Standout
Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
2014
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum
2002
The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
2000
The cornified envelope: a model of cell death in the skin
2005 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Cathepsin S Activity is Detectable in Human Keratinocytes and is Selectively Upregulated upon Stimulation with Interferon-γ
2002
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Human Tenascin Gene
1995
Type 2 diabetes
2017 Standout
Glucagon-like peptide 1(GLP-1) in biology and pathology
2005
Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors
1997
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
2005
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
1999
Ileal release of glucagon-like peptide-1 (GLP-1)
1995
Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis
1994
Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody
1999 StandoutNobel
Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem
1997
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose)
1995
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
2004
Expansion of Cortical Interstitium Is Limited by Converting Enzyme Inhibition in Type 2 Diabetic Patients with Glomerulosclerosis
1999
Protein Kinase Cζ Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells
2006
Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man
1994
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine
2003
Azobenzene photoswitches for biomolecules
2011 Standout
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
2010
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal vein
1996
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
1995
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
A role for glucagon-like peptide-1 in the central regulation of feeding
1996 StandoutNature
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
2016
Glucagon-Like Peptide-1-(7–36) Amide and Peptide YY Mediate Intraduodenal Fat-Induced Inhibition of Acid Secretion in Dogs*
1998
Cell Biology of the Glomerular Podocyte
2003 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic Receptors1
1997
Local, exendin-(9—39)-insensitive, site of action of GLP-1 in canine ileum
2002
Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow
1998
Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
2002
Introduction to the human gut microbiota
2017 Standout
Peripheral Exendin-4 and Peptide YY3–36 Synergistically Reduce Food Intake through Different Mechanisms in Mice
2005
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
1996
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
1997
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
1996
Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery
2006
Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.
1996
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line
2003
A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion
2001
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.
1993
The Glucagon-Like Peptides
1999
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
2002
Glucagon-like peptide-1, a new hormone of the entero-insular axis
1992
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
1998 Standout
Gut hormone PYY3-36 physiologically inhibits food intake
2002 StandoutNature
Gut chemosensing mechanisms
2015
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.
1996
ENTEROGLUCAGON
1997
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day
1996
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
1993
Works of R. Eissele being referenced
Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study
1994
Reciprocal Cellular Distribution of Glucagon-like Peptide-1 (GLP-1) Immunoreactivity and GLP-1 Receptor mRNA in Pancreatic Islets of Rat
1997
Proliferation of endocrine cells in the rat stomach caused by drug-induced achlorhydria
1991
Rat gastric somatostatin and gastrin release: Interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide
1994
Expression, Intracellular Localization, and Gene Transcription Regulation of the Secretory Protein 7B2 in Endocrine Pancreatic Cell Lines and Human Insulinomas
1994
Effect of Glucagon-Like Peptide-1 on Gastric Somatostatin and Gastrin Secretion in the Rat
1990
Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria
1992
The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; ‘morphine modulating peptides’) on the endocrine and exocrine rat pancreas
1990
Studies on the Viability of the Isolated Vascularly Perfused Rat Colon
1996
Helodermin and islet hormone release in isolated rat pancreas
1991
Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreas
1990
Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach
1999
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
1992
Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach
2000
Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors
2003
Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
1990
Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.
1988
Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
1989
Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats
1987
Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
1996
Nephrotoxicity of cyclosporine A in the rat. II. Reversible changes in intranephronal and urinary catalytic activities of N-acetyl-beta-D-glucosaminidase.
1993